Income statement
USD
| Metric | 2026 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.4B | 1.7B | 1.9B | 2.1B | 2.2B |
| Gross Profit | 833M | 1.0B | 1.1B | 1.2B | 1.3B |
| Operating Income | 4M | 23M | 23M | 68M | 194M |
| EBITDA | 57M | 89M | 95M | 135M | 254M |
| Net Income | -132M | -20M | -15M | 37M | 154M |
| EPS (Diluted) | — | — | — | — | — |
Consumer Cyclical
Live Price
Offline$0.21
-46.15% today
1Y Change
-96.77%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sleep Number Corporation (SNBR) is a Consumer Cyclical stock with a market cap of $70.00M and listed on NASDAQ. The stock last traded around $0.21 and down 96.8% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of -16.1%, EPS growth of -541.1%, a dividend yield of 0.0%. What stands out right now is revenue -16.1%, EPS -541.1%, free cash flow -586.3% with operating margin -3.1% and ROIC -9.9%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SNBR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SNBR
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SNBR Max Drawdown
-98.19%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SNBR and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$2.2B
+3.3% YoY
FY Net Income
$153.7M
+320.0% YoY
Free Cash Flow
$233.1M
+799.7% YoY
Revenue Growth
-16.1%
EPS Growth
-541.1%
Gross Margin
59.0%
Net Margin
-9.3%
Income statement
USD
| Metric | 2026 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.4B | 1.7B | 1.9B | 2.1B | 2.2B |
| Gross Profit | 833M | 1.0B | 1.1B | 1.2B | 1.3B |
| Operating Income | 4M | 23M | 23M | 68M | 194M |
| EBITDA | 57M | 89M | 95M | 135M | 254M |
| Net Income | -132M | -20M | -15M | 37M | 154M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2026 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2M | 2M | 3M | 2M | 2M |
| Total Assets | 680M | 861M | 951M | 954M | 920M |
| Total Liabilities | 1.3B | 1.3B | 1.4B | 1.4B | 1.3B |
| Shareholder Equity | -578M | -452M | -442M | -438M | -425M |
| Total Debt | 943M | 936M | 973M | 896M | 791M |
| Net Debt | 941M | 934M | 970M | 894M | 789M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
300M
+730.2% YoY
Capital Expenditures
67M
+3.7% YoY
Free Cash Flow
233M
+799.7% YoY
Key ratios
Gross Margin
59.0%
Operating Margin
-3.1%
Net Margin
-9.3%
ROE
25.9%
Debt / Equity
-1.63x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.